Replies to post #743721 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Are you still on your most likely window by end of January thought process? Or has something changed that sentiment.

[iclight]

You're welcome.

IRP didn't start until January 1, 2024 and AdroFeme was submitted in 2023.

IRP will be open to applicants that have already received an authorisation for the same product from one of MHRA’s specified reference regulators (RRs). A CHMP positive opinion or an MRDC positive end of procedure outcome is an RR authorisation for the purposes of IRP.

So you are wrong. Again. And your guess on DCVax-L will be AGAIN.